Advanced search
Publication Cover
ClinicoEconomics and Outcomes Research Volume 12, 2020 - Issue
Submit an article Journal homepage
293
Views
14
CrossRef citations to date
0
Altmetric
Review

Humanistic and Economic Burden of Non-Muscle Invasive Bladder Cancer: Results of Two Systematic Literature Reviews

Lauren J Lee1 Patient Health and Impact, Pfizer Inc, New York, NY, USACorrespondence[email protected]
,
Christina S Kwon2 Evidence Generation, Purple Squirrel Economics, New York, NY, USAORCID Iconhttps://orcid.org/0000-0002-9536-6085
ORCID Icon,
Anna Forsythe2 Evidence Generation, Purple Squirrel Economics, New York, NY, USA
,
Carla M Mamolo3 Patient Health and Impact, Pfizer Inc, Groton, CT, USAORCID Iconhttps://orcid.org/0000-0001-5321-561X
ORCID Icon,
Elizabeth T Masters1 Patient Health and Impact, Pfizer Inc, New York, NY, USA
&
Ira A Jacobs4 Worldwide Research and Development, Pfizer Inc, New York, NY, USA
Pages 693-709 | Published online: 23 Nov 2020

Citations (14)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Yaofen Tu & Zujie Mao. (2023) Identification and Validation of Molecular Subtype and Prognostic Signature for Bladder Cancer Based on Neutrophil Extracellular Traps. Cancer Investigation 41:4, pages 354-368.
Read now

Articles from other publishers (13)

Mrinmayee Joshi, Steven J. Atlas, Molly Beinfeld, Richard H. Chapman, David M. Rind, Steven D. Pearson & Daniel R. Touchette. (2023) Cost-Effectiveness of Nadofaragene Firadenovec and Pembrolizumab in Bacillus Calmette-Guérin Immunotherapy Unresponsive Non–Muscle Invasive Bladder Cancer. Value in Health 26:6, pages 823-832.
Crossref
Yejinpeng Wang, Lingao Ju, Gang Wang, Kaiyu Qian, Wan Jin, Mingxing Li, Jingtian Yu, Yiliang Shi, Yongzhi Wang, Yi Zhang, Yu Xiao & Xinghuan Wang. (2023) DNA polymerase POLD1 promotes proliferation and metastasis of bladder cancer by stabilizing MYC. Nature Communications 14:1.
Crossref
Kaiwei Yang, Hailong Hu, Junlong Wu, Huina Wang, Zhaoxia Guo, Wei Yu, Lin Yao, Feng Ding, Tao Zhou, Wang Wang, Yunkai Wang, Lei Liu, Jing Guo, Shuaipeng Zhu, Xinhao Zhang, Shanbo Cao, Feng Lou, Yuanjie Niu, Dingwei Ye & Zhisong He. (2023) Letter to the Editor: clinical utility of urine DNA for noninvasive detection and minimal residual disease monitoring in urothelial carcinoma. Molecular Cancer 22:1.
Crossref
Rimantė Bandzevičiūtė, Gediminas Platkevičius, Justinas Čeponkus, Arūnas Želvys, Albertas Čekauskas & Valdas Šablinskas. (2023) Differentiation of Urothelial Carcinoma and Normal Bladder Tissues by Means of Fiber-Based ATR IR Spectroscopy. Cancers 15:2, pages 499.
Crossref
Mengqi Zhou, Binrui Yang, Shiwei Zhou, Puyang Yu, Fan Li, Zheng Liu & Henglong Hu. (2022) Will repeat resection after initial transurethral en bloc resection benefit patients with high-risk non-muscle-invasive bladder cancer? A propensity score matching analysis. Journal of Cancer Research and Clinical Oncology.
Crossref
Henglong Hu, Mengqi Zhou, Binrui Yang, Shiwei Zhou, Zheng Liu & Jiaqiao Zhang. (2022) A Systematic Review on the Role of Repeat Transurethral Resection after Initial en Bloc Resection for Non-Muscle Invasive Bladder Cancer. Journal of Clinical Medicine 11:17, pages 5049.
Crossref
Milena Matuszczak, Adam Kiljańczyk & Maciej Salagierski. (2022) A Liquid Biopsy in Bladder Cancer—The Current Landscape in Urinary Biomarkers. International Journal of Molecular Sciences 23:15, pages 8597.
Crossref
Carlos J. Ortiz-Bonilla, Taylor P. Uccello, Scott A. Gerber, Edith M. Lord, Edward M. Messing & Yi-Fen Lee. (2022) Bladder Cancer Extracellular Vesicles Elicit a CD8 T Cell-Mediated Antitumor Immunity. International Journal of Molecular Sciences 23:6, pages 2904.
Crossref
Alessia D’Aloia, Edoardo Arrigoni, Barbara Costa, Giovanna Berruti, Enzo Martegani, Elena Sacco & Michela Ceriani. (2021) RalGPS2 Interacts with Akt and PDK1 Promoting Tunneling Nanotubes Formation in Bladder Cancer and Kidney Cells Microenvironment. Cancers 13:24, pages 6330.
Crossref
Ekaterina Laukhtina, Sung Ryul Shim, Keiichiro Mori, David D‘Andrea, Francesco Soria, Pawel Rajwa, Hadi Mostafaei, Eva Compérat, Alessia Cimadamore, Marco Moschini, Jeremy Yuen-Chun Teoh, Dmitry Enikeev, Evanguelos Xylinas, Yair Lotan, Juan Palou, Paolo Gontero, Marko Babjuk, J. Alfred Witjes, Ashish M. Kamat, Morgan Roupret, Shahrokh F. Shariat & Benjamin Pradere. (2021) Diagnostic Accuracy of Novel Urinary Biomarker Tests in Non–muscle-invasive Bladder Cancer: A Systematic Review and Network Meta-analysis. European Urology Oncology 4:6, pages 927-942.
Crossref
Pooja Jain, Himanshu Kathuria & Munira Momin. (2021) Clinical therapies and nano drug delivery systems for urinary bladder cancer. Pharmacology & Therapeutics 226, pages 107871.
Crossref
Carissa Chu & Sima Porten. 2021. Comprehensive Diagnostic Approach to Bladder Cancer. Comprehensive Diagnostic Approach to Bladder Cancer 1 12 .
. (2020) Burden of non-muscle invasive bladder cancer substantial. PharmacoEconomics & Outcomes News 868:1, pages 6-6.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.